-
-
Call more information
660-596-2224 -
Authors: Brian Chanpong DDS, MSc Anesth Prog (2020) Dental professionals are at an increased risk for exposure to the severe acute respiratory syndrome coronavirus 2 with aerosol-generating procedures (AGPs), and dental anesthesia practices have additional risks due to airway management procedures. The purpose of this pilot study was to examine the extent of splatter on dental […]
Read MoreAuthor: Suzanne Smalley Yahoo News A new opioid developed for the Pentagon could fill drug shortages wrought by the coronavirus — but the FBI says it’s dangerous In October 2018, Dr. Raeford Brown was attending a meeting of the American Society of Anesthesiologists in San Francisco when, back in Washington, the Food and Drug Administration […]
Read MoreAuthor: Janell Penha, PharmD Pharmacy Times Ephedrine is a critical medication needed for hypotensive emergencies in patients in the operating room. The pharmacy department is generally responsible for making prepared syringes to be distributed prior to procedures. If during a surgery a patient becomes hypotensive, the prepared syringes will be administered to the patient. An […]
Read MoreBy Brian P. Dunleavy UPI As many as 37 percent of all American adults have metabolic syndrome, placing them at increased risk for heart disease and other health problems, according to a study published Tuesday by JAMA. In addition, nearly half of all U.S. adults aged 60 years and older have the condition, the researchers said.Metabolic […]
Read MoreAuthor: Michael Walter Cardiovascular Business News The stroke rate among COVID-19 patients is low, according to new research published in Stroke. Cryptogenic stroke is more common than normal, however, and in-hospital mortality is significantly higher. “Given early reports of an association between COVID-19 and cerebrovascular disease, there is a critical, unmet need to define associations and outcomes of […]
Read MoreAuthor: Michael Walter Cardiovascular Business Neuroscientists have developed a new protein, TAT-DP-2, that could limit stroke-related brain damage, sharing their findings in Science Advances. The protein was designed to prevent cell death through the disruption of two specific Kv2.1 channels. This keeps potassium from leaving the cells in question, which completely changes how they react during […]
Read MoreAUTHORS: Sylvie D. Aucoin, M.D., M.Sc., F.R.C.P.C. et al Anesthesiology 7 2020, Vol.133, 78-95. Background: A barrier to routine preoperative frailty assessment is the large number of frailty instruments described. Previous systematic reviews estimate the association of frailty with outcomes, but none have evaluated outcomes at the individual instrument level or specific to clinical assessment of frailty, […]
Read MoreBy Pat Anson Pain News Network Editor An experimental non-opioid pain reliever gives long-term relief for chronic low back pain, but questions remain about joint damage and other side effects from the drug, according to a large new study. Tanezumab is a humanized monoclonal antibody that targets nerve growth factor (NGF), a protein in the […]
Read MoreAUTHORS: Yeoh, Cindy B. MD et al Anesthesia & Analgesia: July 2020 – Volume 131 – Issue 1 – p 16-23 Abstract The novel coronavirus disease 2019 (COVID-19) was first reported in China in December 2019. Since then, it has spread across the world to become one of the most serious life-threatening pandemics since the […]
Read MoreAuthor: Michael Walter Cardiovascular Business News A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology. There are multiple P2Y12 receptor antagonists currently available, the authors explained, but the antiplatelet effect often takes too long to […]
Read More